(Q46373710)

21 December 2017

title

Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease (English)

1 reference

21 December 2017

author name string

Hirofumi Yano

1

1 reference

21 December 2017

Yoshifuru Tamura

2

1 reference

21 December 2017

Kana Kobayashi

3

1 reference

21 December 2017

Masayuki Tanemoto

4

1 reference

21 December 2017

Shunya Uchida

5

1 reference

21 December 2017

publication date

13 April 2013

1 reference

21 December 2017

Clinical and experimental nephrology

published in

1 reference

21 December 2017

volume

18

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

50-55

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s10157-013-0806-8

exact match

0 references

cites work

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

SLC2A9 influences uric acid concentrations with pronounced sex-specific effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

Genome-wide association study of hematological and biochemical traits in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

Decreased extra-renal urate excretion is a common cause of hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

Vitamin D deficiency and renal calcium transport in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

The role of hyperuricemia in vascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

Hyperuricemia and gout. Classification, complications and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0806-8

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

21 January 2018

1 reference

12 December 2020

Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

1 reference

12 December 2020

Origin and Extrarenal Elimination of Uric Acid in Man

1 reference

12 December 2020

Molecular identification of a renal urate anion exchanger that regulates blood urate levels

1 reference

12 December 2020

Role of the intestinal tract in the elimination of uric acid

1 reference

12 December 2020

Uric acid and cardiovascular risk

1 reference

12 December 2020

Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial

1 reference

12 December 2020

Effect of chronic experimental renal insufficiency on urate metabolism.

1 reference

12 December 2020

The effect of 1-alpha-hydroxycholecalciferol on the renal handling of phosphate in parathyroidectomized man.

1 reference

12 December 2020

10.1007/S10157-013-0806-8

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017